Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Fig 3

Sequential changes of serum alfa-fetoprotein (AFP).

Serum AFP levels before therapy and six months after the end of the treatment in patients treated with peg-interferon plus ribavirin (PEG-IFN/RBV) or daclatasvir plus asunaprevir (DCV/ASV). In these box-and-whisker plots, lines within the boxes represent median values; the upper and lower lines of the boxes represent the 75th and 25th percentiles, respectively; the upper and lower bars outside the boxes represent the 90th and 10th percentiles, respectively.

Fig 3